Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:24 PM
Ignite Modification Date:
2025-12-24 @ 7:24 PM
NCT ID:
NCT00071903
Eligibility Criteria:
* INCLUSION CRITERIA:
The inclusion criteria include only a confirmed diagnosis of pseudotumor cerebri (past or present) in a patient with nephropathic cystinosis. Patients will be diagnosed as having pseudotumor cerebri based upon modified Dandy criteria:
1. signs and symptoms related to increased intracranial pressure;
2. no localizing neurological signs with the exception of unilateral or bilateral sixth nerve palsy;
3. neuroimaging study showing no mass lesion or hydrocephalus;
4. elevated opening pressure with normal cerebrospinal fluid contents on lumbar puncture.
Nephropathic cystinosis patients of all ages who meet the Dandy criteria for PTC will be considered for the study.
EXCLUSION CRITERIA:
Pregnant patients will be excluded from the study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
2 Years
Maximum Age:
50 Years
Study:
NCT00071903
Study Brief:
Protocol Section:
NCT00071903